Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03296875

Ligand	Ligand name	Chain	PDB	Tanimoto
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.7
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.74
803	LOVASTATIN	A,B	1CQP	0.74
E7B		A,B	3E7B	0.72
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.73
11O	(TRANS-12,13-EPOXY)-11-HYDROXY-9(Z)-OCTADECENOIC ACID	A	1IK3	0.7
GGD	NONADEC-10-ENOIC ACID 2-[3,4-DIHYDROXY-6-HYDROXYMETHYL-5-(3,4,5-TRIHYDROXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-TETRAHYDRO-PYRAN-2-YLOXY]-1-OCTADEC-9-ENOYLOXYMETHYL-ETHYL ESTER	H,L,M	2J8C	0.79
GGD	NONADEC-10-ENOIC ACID 2-[3,4-DIHYDROXY-6-HYDROXYMETHYL-5-(3,4,5-TRIHYDROXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-TETRAHYDRO-PYRAN-2-YLOXY]-1-OCTADEC-9-ENOYLOXYMETHYL-ETHYL ESTER	L,M	1M3X	0.79
SXN	Salinixanthin	A,B	3DDL	0.76
RGC	REIDISPONGIOLIDE C	A	2ASP	0.72
PIE	1,2-DIACYL-SN-GLYCERO-3-PHOSPHOINOSITOL	A,B,C,D	1UW5	0.7
PIE	1,2-DIACYL-SN-GLYCERO-3-PHOSPHOINOSITOL	A,C,D,E	1KB9	0.7
RCL	RICINOLEIC ACID	A	2CM4	0.72
RCL	RICINOLEIC ACID	A	2CM9	0.72
RCL	RICINOLEIC ACID	A	1FK7	0.72
GMM	GLUCOSE MONOMYCOLATE	A	1UQS	0.87
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2C6H	0.71
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2CA0	0.71
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2CD8	0.71
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2VZ7	0.71
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.7
EAH	(5S,7E,9E,11Z,14Z)-5-hydroxyicosa-7,9,11,14-tetraenoic acid	A	3DZT	0.7
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.75
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8P	0.7
DEB	6-DEOXYERYTHRONOLIDE B	A	1JIO	0.7
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8Q	0.7
DEB	6-DEOXYERYTHRONOLIDE B	A	1OXA	0.7
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8O	0.7
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	2RCL	0.72
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	3DSK	0.72
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.76
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.73
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.73
MRC	MUPIROCIN	A	1JZS	0.75
MRC	MUPIROCIN	A,T	1FFY	0.75
MRC	MUPIROCIN	A	1QU3	0.75
MRC	MUPIROCIN	A,T	1QU2	0.75
B7N	(1R)-2-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate	A	3B7N	0.7
B7N	(1R)-2-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate	A	3B7Z	0.7
114	COMPACTIN	A,B,C,D	1HW8	0.76
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.76
PUL		A	2C78	0.74
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.78
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.75
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.72
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.71